Literature DB >> 9891152

CT imaging of intrathoracic lymph nodes in dogs with bronchoscopically administered iodinated nanoparticles.

L H Ketai1, B A Muggenberg, G L McIntire, E R Bacon, R Rosenberg, P E Losco, J L Toner, K J Nikula, P Haley.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of the study was to determine if airway instillation of iodinated nanoparticles results in contrast material enhancement of tracheobronchial lymph nodes in dogs.
MATERIALS AND METHODS: Eight dogs underwent intrabronchial instillation of iodinated nanoparticles; six dogs received 900 mg each, and two dogs received 450 mg each. Spiral computed tomography (CT) was then performed 2-34 days later.
RESULTS: CT scans obtained 2 days after instillation showed the presence of contrast material within the lung parenchyma but no nodal enhancement. Scans obtained 6-34 days after instillation showed enhancement of the right, left, and middle tracheobronchial lymph nodes (analogous to the mediastinal nodes in humans). Mean nodal attenuation on CT images was 117 HU +/- 43, and the mean nodal volume was 129 mm3 +/- 113. Histologic specimens of the nodes showed macrophage hyperplasia.
CONCLUSION: Iodinated nanoparticles instilled into small airways are transported to the tracheobronchial lymph nodes, where they result in contrast enhancement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9891152     DOI: 10.1016/s1076-6332(99)80061-0

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  3 in total

Review 1.  Micro-computed tomography of the lungs and pulmonary-vascular system.

Authors:  Erik L Ritman
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.

Authors:  Kristin L Aillon; Nashwa El-Gendy; Connor Dennis; Jeffrey P Norenberg; Jacob McDonald; Cory Berkland
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  Formulating paclitaxel in nanoparticles alters its disposition.

Authors:  Teng Kuang Yeh; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.